Literature DB >> 27362306

Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival.

Ivar Anders Eide1, Thea Anine Strøm Halden, Anders Hartmann, Dag Olav Dahle, Anders Åsberg, Trond Jenssen.   

Abstract

BACKGROUND: Previous reports indicate that posttransplantation diabetes mellitus (PTDM) is associated with overall renal graft loss, but not death-censored graft loss.
METHODS: In this single-center retrospective cohort study of 2749 adult Norwegian renal transplant recipients, transplanted between 1999 and 2011, we estimated overall and death-censored renal graft loss hazard ratios in patients diagnosed with PTDM, impaired glucose tolerance and diabetes before transplantation, using multivariable Cox proportional hazard regression analysis.
RESULTS: A total of 893 renal grafts were lost during the study period, either due to recipient death (n = 540) or death-censored graft loss (n = 353).When the observational time started at time of transplantation, diabetes before transplantation was associated with both overall and death-censored graft loss. Pretransplantation diabetes was also associated with a steeper decline in renal graft function, a higher risk of acute rejections and more renal grafts lost due to acute rejection.In patients with a functional renal graft 1 year after transplantation, PTDM was associated with overall graft loss (hazard ratio, 1.46; 95% confidence interval, 1.13-1.88; P < 0.001), but not death-censored graft loss (hazard ratio, 1.25; 95% confidence interval, 0.80-1.96; P = 0.33). We found no significant associations between PTDM and change in renal function during the first 5 years or acute rejection risk during the first year after renal transplantation.Impaired glucose tolerance was not associated with either overall or death-censored graft loss.
CONCLUSIONS: The present study confirms previous findings of an increased risk of overall but not death-censored renal graft loss in renal transplant recipients with PTDM. Longstanding diabetes might increase the risk of acute rejections.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27362306     DOI: 10.1097/TP.0000000000001259

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation.

Authors:  Basil Alnasrallah; Tze Liang Goh; Lai Wan Chan; Paul Manley; Helen Pilmore
Journal:  BMC Nephrol       Date:  2019-04-29       Impact factor: 2.388

2.  Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Manjunatha T A; Rebecca Chng; Wai-Ping Yau
Journal:  Ann Transplant       Date:  2021-12-29       Impact factor: 1.530

Review 3.  Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach.

Authors:  Didier Ducloux; Cécile Courivaud
Journal:  J Pers Med       Date:  2022-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.